The Role of HIPRPL29 in Prostate Cancer - PowerPoint PPT Presentation

1 / 24
About This Presentation
Title:

The Role of HIPRPL29 in Prostate Cancer

Description:

Supernatant. Spin 2 hours at 78,000 x G. Spin 2.5 hours at 105,000 ... Supernatant (Cytoplasmic fraction) Pellet (nuclei, large membrane fragments, cell debris) ... – PowerPoint PPT presentation

Number of Views:78
Avg rating:3.0/5.0
Slides: 25
Provided by: Lyn847
Category:

less

Transcript and Presenter's Notes

Title: The Role of HIPRPL29 in Prostate Cancer


1
The Role of HIP/RPL29 in Prostate Cancer
  • Lynn Schwarting-Opdenaker
  • Advisor Cindy Farach-Carson

2
HIP/RPL29Heparin/Heparan Sulfate Interacting
Protein/ Ribosomal Protein L29
  • 159 amino acids (human mouse and pig have 160)
  • Apparent MW of 24-28kDa on SDS-PAGE
  • Highly basic
  • Contains polyanionic binding sites
  • 84.4 similarity at the protein level between
    mouse and human
  • No prokaryotic ortholog

3
Predicted Structure and Functions of HIP/RPL29
  • Polyanion binding
  • Translational regulation (RNA binding?)
  • Modulation of blood coagulation via heparin
    binding
  • High affinity HP/HS binding
  • Adhesion and invasion of trophoblasts and cancer
    cells
  • Inhibition of heparanase
  • Antagonist of HB growth factor response

Basic residues in blue
4
HIP/RPL29 Potential FunctionsProtein Synthesis
The mammalian ribosome reconstructed by electron
microscopy
  • Peripheral protein?
  • Stabilizes RNA-protein interactions?
  • Increases ribosome translational efficiency?

5
HIP/RPL29 Protein Expression Increases with
Phenotypic Progression in Various Prostate Cancer
Cell Lines
PREC LNCaP C4-2 C4-2B PC3 DU145
49 kD
B-actin
28 kD
HIP
6
HIP/RPL29 Protein Expression in Different Bone
Marrow Cells
HIP/RPL29 Nuclei
7
Hypotheses
  • Modifying HIP/RPL29 expression in lineage related
    prostate cancer cells will alter their growth and
    progression.
  • By reducing HIP/RPL29 expression in prostate
    cancer cells, we predict that this will
    negatively regulate growth and tumor progression.

8
Comparison of HIP/RPL29 Expression in Human Cell
Lines
9
FACS Analysis of Cell Surface HIP/RPL29
10
Ribosome Isolation of HIP/RPL29
Lift cells with PBS 10mM EDTA
Dounce Homogenize 100 strokes
Spin 15 min at 13,000 x G
Supernatant
Pellet (nuclei, large
membrane fragments, cell debris)
Spin 2 hours at 78,000 x G
Pellet
Supernatant (Cytoplasmic fraction)
Add Triton-X and Sodium Deoxycholate
Spin 15 min at 13,000 x G
Supernatant
Pellet (insoluble material)
Layer over 0.5M sucrose
Spin 2.5 hours at 105,000 x G
11
Subcellular Fractionation
  • There is little or no HIP/RPL29 on the cell
    surface of the LNCaP and C4-2B cell lines in
    standard culture conditions
  • HIP/RPL29 in these cells is intracellular and
    follows the pattern of ribosomal protein L4
  • The intracellular function of HIP/RPL29 in
    prostate cancer is the focus of further work for
    this project

12
Strategy to Study HIP/RPL29
  • Used a ribozyme as a tool to reduce expression
  • Created C4-2B cell lines stably expressing
    HIP/RPL29 ribozyme
  • Assay for knockdown and affect of HIP/RPL29
    reduced expression

13
Initial Look at Knockdown Clones
Relative HIP/RPL29 Expression
49
48
58
61
14
Soft Agar Assay
Parental
Clone 9
Clone 20
Clone 22
15
Rebound of Knockdown Clones
Relative HIP/RPL29 Expression Determined by
Western Blot
HIP/b-actin ratio
Cell Line
16
Lentiviral titering
HIP ribozyme Lenti Clone 3 concentrated with
polybrene C4-2B cells
HIP ribozyme Lenti Clone 3 concentrated C4-2B
cells
10-2
10-3
0
10-3
10-2
0
10-4
10-5
10-6
10-5
10-4
10-6
10-3
10-2
0
10-3
10-2
0
10-6
10-5
10-4
10-6
10-5
10-4
HIP ribozyme Lenti Clone 3 with polybrene C4-2B
cells
HIP ribozyme Lenti Clone 3 ATDC5 cells
17
Lentivirus yields HIP/RPL29 ribozyme knockdown
clones
18
Conclusions
  • Creation of stable HIP/RPL29 knockdown clones has
    not been feasible due to rebound effect
  • C4-2B cells do not express the receptors
    necessary to transduce at a high rate with
    lentivirus
  • Alternatives include
  • Adenovirus (transient)
  • Inducible promoter in C4-2B

19
Use of Adenovirus to deliver HIP/RPL29 Ribozyme
  • Cannot create stables must use transient
    transfections
  • Could not obtain a knockdown of HIP/RPL29 using
    this method
  • Never saw more than a 28 knockdown
  • Higher MOIs caused cell death

20
Creation of an Inducible System to Deliver the
HIP/RPL29 Ribozyme
  • Chose to use an ecdysone-inducible system
  • Advantages include low background expression,
    high induction, can be used in animal models as
    well
  • Creation of double stable clones needed

21
Ecdysone-Inducible System
GR glucocorticoid receptor EcR ecdysone
receptor VgEcR fusion of ligand-binding and
dimerization domain of EcR, DNA binding domain of
GR and transcriptional activation domain of HSV
VP16 Minimal promoter 3 SP1 binding sites and
minimal heat shock promoter (mHSP)
http//www.stratagene.com/manuals/217468.pdf
22
Vectors needed to create Ecdysone System
23
(No Transcript)
24
Ongoing Work
  • Create second set of stable clones using the
    C4-2B cell lines expressing the highest levels of
    the receptors (clones 7 and 34)
  • Analyze the HIP/RPL29 knockdown mice that we have
    recently obtained for changes in prostate
    size/morphology
Write a Comment
User Comments (0)
About PowerShow.com